Listed here are three shares added to the Zacks Rank #5 (Robust Promote) Record at the moment:
Agios Prescription drugs, Inc. AGIO is a biopharmaceutical firm. The Zacks Consensus Estimate for its present 12 months earnings has been revised 19.7% downward during the last 60 days.
Chegg, Inc. CHGG is an individualized studying assist supplier. The Zacks Consensus Estimate for its present 12 months earnings has been revised 96.8% downward during the last 60 days.
Equifax Inc. EFX is an information, analytics, and know-how firm.The Zacks Consensus Estimate for its present 12 months earnings has been revised 11.3% downward during the last 60 days.
View your complete Zacks Rank #5 List.
Zacks’ Analysis Chief Names “Inventory Most More likely to Double”
Our staff of consultants has simply launched the 5 shares with the best chance of gaining +100% or extra within the coming months. Of these 5, Director of Analysis Sheraz Mian highlights the one inventory set to climb highest.
This prime decide is among the many most revolutionary monetary corporations. With a fast-growing buyer base (already 50+ million) and a various set of leading edge options, this inventory is poised for giant positive aspects. After all, all our elite picks aren’t winners however this one may far surpass earlier Zacks’ Shares Set to Double like Nano-X Imaging which shot up +129.6% in little greater than 9 months.
Free: See Our Top Stock And 4 Runners Up
Equifax, Inc. (EFX) : Free Stock Analysis Report
Agios Pharmaceuticals, Inc. (AGIO) : Free Stock Analysis Report
Chegg, Inc. (CHGG) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
